References
- Goff DC, Hill M, Freudenreich O. Strategies for improving
treatment adherence in Schizophrenia and Schizoaffective disorder. J Clinical
Psychiatry. 2010;71(suppl 2):20-6. PubMed | Google Scholar
- Rummel-Kluge C, Schuster T, Peters S, Kissling W.
Partial compliance with antipsychotic medication is common in patients
with schizophrenia. Aust N Z J Psychiatry. 2008; 42(5):382-8. PubMed | Google Scholar
- Masand M, Roca M, Turner M, Kane J. Partial Adherence
to Antipsychotic Medication Impacts the Course of Illness in Patients
With Schizophrenia: a review primary care companion. J Clinical Psychiatry.
2009; 11(4):147-54. PubMed | Google Scholar
- Ascher-Svanum H, Zhu B, Faries DE, Furiak NM, Montgomery
W. Medication adherence levels and differential use of mental-health
services in the treatment of schizophrenia. BMC Res Notes. 2009;2:6. PubMed | Google Scholar
- Thieda P, Beard S, Richter A, Kane J. An economic
review of com ¬pliance with medication therapy in the treatment of schizophrenia. Psychiatr Serv. 2003;54(4):508-516. PubMed | Google Scholar
- Tatiana Dilla, Antonio Ciudad, María Álvarez. Systematic review of the economic aspects of nonadherence to antipsychotic medication in patients with schizophrenia. Dove Medical Press Patient Preference and Adherence. 2013;7: 275-284. PubMed | Google Scholar
- Sun SX, Liu GG, Christensen DB, Fu AZ. Review and
analysis of hospitalization costs associated with antipsychotic nonadherence
in the treatment of schizophrenia in the United States. Curr Med Res
Opin. 2007;23(10):2305-2312. PubMed | Google Scholar
- Freudenreich O, Tranulis C. A prototype approach
toward antipsychotic medication adherence in schizophrenia. Harv Rev
Psychiatry. 2009;17(1):35-40. PubMed | Google Scholar
- Misdrahi D, Llorca PM, Lancon C, And Bayle FJ. L'observance
dans la schizophr énie: facteurs prédictifs, voies de recherche, implications thérapeutiques. Encephale. 2002 ; 28 (3) : 266-72. PubMed | Google Scholar
- Chadzynska M, Meder J, Tyszkowska M. Compliance
in the treatment of schizophrenia-project ADHES (the renewed results).
Psychiatr Pol. 2008 Jul-Aug;42(4):561-70. PubMed | Google Scholar
- Velligan DI, Wang M, Diamond P, et al. Relationships
among subjective and objective measures of adherence to oral antipsychotic
medications. Psychiatr Serv. 2007;58(9):1187-1192. PubMed | Google Scholar
- Cramer JA, Rosenheck R. Compliance with medication
regimens for mental and physical disorders. Psychiatr Serv. 1998;49(2):196-201. PubMed | Google Scholar
- Velligan DI, Lam YW, Glahn DC, et al. Defining
and assessing adher ¬ence to oral antipsychotics: a review of the literature. Schizophr Bull. 2006;32(4):724-742. PubMed | Google Scholar
- Sellwood W, Tarrier N, Quinn J, Barrowclough C.
The family and compliance in schizophrenia: the influence of clinical
variables, relatives knowledge and expressed emotion. Psychol Med. 2003;
33(1): 91-6. PubMed | Google Scholar
- Kampman O, Laippala P, Vaananene J,Koivisto E,
Kiviniemi P,Kilkku N, Lehtinen K. Indicators of medication compliance
in first-episode psychosis. Psychiatry Res. 2002;110(1): 39-48. PubMed | Google Scholar
- Glick ID, Stekoll AH, Hays S. The role of the family
and improvement in treatment maintenance, adherence, and outcome for
schizophrenia. J Clin Psychopharmacol. 2011 Feb;31(1):82-5. PubMed | Google Scholar
- Gilmer Todd P, Ojeda Victoria D, Barrio Concepcion,
Fuentes Dahlia, Garcia Piedad, Lanouette Nicole M, Lee Kelly C. Adherence
to antipsychotics among Latinos and Asians with schizophrenia and limited
English proficiency. Psychiatr Serv. 2009 February ; 60(2): 175-182. PubMed | Google Scholar
- DiBonaventura Marco, Gabriel Susan, Dupclay Leon,
Gupta1 Shaloo, Kim Edward. A patient perspective of the impact of medication
side effects on adherence: results of a cross-sectional nationwide survey
of patients with schizophrenia. BMC Psychiatry. 2012; 12:20. PubMed | Google Scholar
- Miller R, Ream G, McCormack J, Gunduz-Bruce H,
Sevy S, Robinson D. A prospective study of cannabis use as a risk factor
for non-adherence and treatment dropout in first-episode schizophrenia.
Schizophr Res. 2009 Sep;113(2-3):138-44. PubMed | Google Scholar
- Buckley PF. Substance abuse in schizophrenia :
a review. J Clin Psychiatry. 1998;59 (Suppl 3) : 26-30. PubMed | Google Scholar
- Droulout T, Liraud F, Verdoux H. Relationships
between insight and medication adherence in subjects with psychosis.
Encephale. 2003; 29(5): 430-7. PubMed | Google Scholar
- Paillot CM, Ingrand P, Ingrand I, Jaafari N. L'insight
et les croyances relatives aux m édicaments influencent l'observance médicamenteuse dans la schizophénie. Annales medio-psychologiques .2011;169: 446-448.. PubMed | Google Scholar
- Van Putten et coll. Drug refusal in schizophrenia
and the wish to be crazy. Arch Gen Psychiatry. 1974 ; 31 : 67-72. PubMed | Google Scholar
- Charpentier A, Goudemand M, Thomas P. Therapeutic
alliance, a stake in schizophrenia. Encephale. 2009 Feb;35(1):80-9. PubMed | Google Scholar
- Roman B. Patients' attitudes towards generic substitution
of oral atypical antipsychotics: a questionnaire-based survey in a hypothetical
pharmacy setting. CNS Drugs. 2009 Aug;23(8):693-701. PubMed | Google Scholar
- Treur M, Heeg B, Möller HJ, Schmeding A, van Hout B. A pharmaco-economic analysis of patients with schizophrenia switching to generic risperidone involving a possible compliance loss. BMC Health Serv Res. 2009 Feb18;9:32. PubMed | Google Scholar
- Borras L, Mohr S, Brandt PY, Gilliéron C, Eytan A, Huguelet P. Religious beliefs in schizophrenia: their relevance for adherence to treatment. Schizophr Bull. 2007 Sep;33(5):1238-46. PubMed | Google Scholar
- Gilmer TP, Dolder CR, Lacro JP, et al. Adherence
to treatment with antipsychotic medication and health care costs among
Medicaid beneficiaries with schizophrenia. American Journal of Psychiatry.
2004; 161(4):692-699. PubMed | Google Scholar
- Santé en chiffres 2011 Ministère de la santé Maroc, siteweb : santé.gov.ma(Accessed on September 15, 2013). Google Scholar
- Desbrus-Qochih A, Cathébras P. Obéir ou adhérer ? L'observance thérapeutique en question. Médecine & Longévité. 2012 ;4(3-4) :111-122. PubMed | Google Scholar
- Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter
D, Ross R, Docherty JP. Assessment of adherence problems in patients
with serious and persistent mental illness: recommendations from the
Expert Consensus Guidelines. J Psychiatr Pract. 2010 Jan;16(1):34-45. PubMed | Google Scholar
- Barkhof E, Meijer CJ, de Sonneville LM, Linszen
DH, de Haan L. Interventions to improve adherence to antipsychotic medication
in patients with schizophrenia-a review of the past decade. Eur Psychiatry.
2012 Jan;27(1):9-18. PubMed | Google Scholar
- Citrome L. Oral antipsychotic update: a brief review
of new and investigational agents for the treatment of schizophrenia.
CNS Spectr. 2012 Nov;17 (Suppl 1):1-9. PubMed | Google Scholar
- Pfeiffer PN, Ganoczy D, Valenstein M. Dosing frequency
and adherence to antipsychotic medications. Psychiatr Serv. 2008 Oct;59(10):1207-10. PubMed | Google Scholar
- Schennach-Wolff R, Jäger M, Seemüller F, Obermeier M, Messer T, Laux G, Pfeiffer H, Naber D, Schmidt LG, Gaebel W, Klosterkötter J,Heuser I, Maier W, Lemke MR, Rüther E, Klingberg S, Gastpar M, Möller HJ, Riedel M. Attitude towards adherence in patients with schizophrenia at discharge. J Psychiatr Res. 2009 Dec;43(16):1294-301. PubMed | Google Scholar
- Barbui C, Kikkert M, Mazzi MA, Becker T, Bindman
J, Schene A, Nos è M, Helm H, Thornicroft G, Tansella M. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence. Psychopathology. 2009;42(5):311-7. PubMed | Google Scholar
- Park EJ, Amatya S, Kim MS, Park JH, Seol E, Lee
H, Shin YH, Na DH. Long-acting injectable formulations of antipsychotic
drugs for the treatment of schizophrenia. Arch Pharm Res. 2013 Jun;36(6):651-9. PubMed | Google Scholar
- Hong J, Novick D, Brugnoli R, Bertsch J, Haro JM.
Changes in adherence and treatment costs following initiation of oral
or depot typical antipsychotics among previously non-adherent patients
with schizophrenia. Hum Psychopharmacol. 2013 Jun 15 ; 25(6):439-48. PubMed | Google Scholar
- Novick D, Haro JM, Bertsch J, Anand H, Jemiai N,
Haddad PM. Comparison of treatment discontinuation and hospitalization
among nonadherent patients initiating depot or oral typical antipsychotic
medications. Int Clin Psychopharmacol. 2012 Sep;27(5):275-82. PubMed | Google Scholar
- Liu-Seifert H, Osuntokun OO, Feldman PD. Factors
associated with adherence to treatment with olanzapine and other atypical
antipsychotic medications in patients with schizophrenia. Compr Psychiatry.
2012 Jan;53(1):107-15. PubMed | Google Scholar
- Isabelle de Beauchamp, Diane Lévy-Chavagnat, Jean-Jacques
Chavagnat. Éducation thérapeutique et schizophrénie : Quels buts ? Actualités
Pharmaceutiques. 2013;52 (N° 524S) :8-13. PubMed | Google
Scholar
- Kampman O, Illi A, Poutanen P, Leinonen E. Four-year
outcome in non-compliant schizophrenia patients treated with or without
home-based ambulatory outpatient care. Eur Psychiatry. 2003; 18(1): 15. PubMed | Google Scholar
- Cañas F, Alptekin K, Azorin JM, Dubois V, Emsley R, García AG, Gorwood P, Haddad PM, Naber D, Olivares JM, Papageorgiou G, Roca M. Improving treatment adherence in your patients with schizophrenia: the STAY initiative. Clin Drug Investig. 2013 Feb;33(2):97-107. PubMed | Google Scholar